Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow References
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Perrone-Filardi, P.
Right arrow Articles by Chiariello, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Perrone-Filardi, P.
Right arrow Articles by Chiariello, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


Coronary artery disease and intermittent claudication: how to manage the patient

P. Perrone-Filardi* and M. Chiariello

Division of Cardiology, Federico II University of Naples, Naples, Italy

* Correspondence: Dr Pasquale Perrone-Filardi, Division of Cardiology, Federico Il University, Via Pansini, 5, 80131 Napoli, Italy.

Abstract

Coexistence of peripheral arterial disease (PAD) and coronary artery disease (CAD) is common. PAD worsens the prognosis of patients with and without CAD. Thus, patients with PAD should be treated for secondary prevention, regardless of the diagnosis of CAD. PAD should be sought in smokers or diabetics aged between 59 and 69 years, in those older than 70 years, in those with known atherosclerotic disease, and in those with suspicion of PAD. As a screening tool, Doppler measurement of the ratio between ankle and arm pressures offers the best approach. Conversely, pharmacological stress imaging should be employed to rule out CAD in PAD patients. Treatment of PAD implies risk factor modification, especially smoking cessation and lipid profile. Pharmacological treatments include preventive drugs and drugs that affect claudication. Unfortunately, few drugs have been proven effective for the latter. These include cilostazol and propionylL-camitine, which ameliorates symptoms and quality of life. It remains unresolved whether different treatment strategies for coexistent CAD impact favourably on prognosis in these problematic patients.

Key Words: Cardiovascular risk • coronary artery disease • peripheral artery disease


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.